BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12859954)

  • 1. Kinetic properties of human thymidylate synthase, an anticancer drug target.
    Sergeeva OA; Khambatta HG; Cathers BE; Sergeeva MV
    Biochem Biophys Res Commun; 2003 Jul; 307(2):297-300. PubMed ID: 12859954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular transformation of the investigational new anticancer drug NB1011, a phosphoramidate of 5-(2-bromovinyl)-2'-deoxyuridine, results in modification of cellular proteins not DNA.
    Sergeeva MV; Cathers BE
    Biochem Pharmacol; 2003 Mar; 65(5):823-31. PubMed ID: 12628478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.
    Lackey DB; Groziak MP; Sergeeva M; Beryt M; Boyer C; Stroud RM; Sayre P; Park JW; Johnston P; Slamon D; Shepard HM; Pegram M
    Biochem Pharmacol; 2001 Jan; 61(2):179-89. PubMed ID: 11163332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.
    Boyer CR; Karjian PL; Wahl GM; Pegram M; Neuteboom ST
    Anticancer Drugs; 2002 Jan; 13(1):29-36. PubMed ID: 11914638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach to thymidylate synthase as a target for cancer chemotherapy.
    Li Q; Boyer C; Lee JY; Shepard HM
    Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
    Neuteboom ST; Karjian PL; Boyer CR; Beryt M; Pegram M; Wahl GM; Shepard HM
    Mol Cancer Ther; 2002 Apr; 1(6):377-84. PubMed ID: 12477050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partitioning roles of side chains in affinity, orientation, and catalysis with structures for mutant complexes: asparagine-229 in thymidylate synthase.
    Finer-Moore JS; Liu L; Schafmeister CE; Birdsall DL; Mau T; Santi DV; Stroud RM
    Biochemistry; 1996 Apr; 35(16):5125-36. PubMed ID: 8611496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2'-deoxyuridine 5'-monophosphate (dUMP)-binding Tyr-261.
    Newby Z; Lee TT; Morse RJ; Liu Y; Liu L; Venkatraman P; Santi DV; Finer-Moore JS; Stroud RM
    Biochemistry; 2006 Jun; 45(24):7415-28. PubMed ID: 16768437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
    Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
    Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan 80 and leucine 143 are critical for the hydride transfer step of thymidylate synthase by controlling active site access.
    Fritz TA; Liu L; Finer-Moore JS; Stroud RM
    Biochemistry; 2002 Jun; 41(22):7021-9. PubMed ID: 12033935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative free energies of binding to thymidylate synthase of 2- and/or 4-thio and/or 5-fluoro analogues of dUMP.
    Jarmuła A; Cieplak P; Leś A; Rode W
    J Comput Aided Mol Des; 2003 Oct; 17(10):699-710. PubMed ID: 15068368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic mechanism of Chlamydia trachomatis flavin-dependent thymidylate synthase.
    Griffin J; Roshick C; Iliffe-Lee E; McClarty G
    J Biol Chem; 2005 Feb; 280(7):5456-67. PubMed ID: 15591067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5-substitution in the pyrimidine ring of dUMP on the interaction with thymidylate synthase: molecular modeling and QSAR.
    Jarmuła A; Cieplak P; Krygowski TM; Rode W
    Bioorg Med Chem; 2007 Mar; 15(6):2346-58. PubMed ID: 17275316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
    Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
    J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure and enzymatic characterization of thymidylate synthase X from Helicobacter pylori strain SS1.
    Wang K; Wang Q; Chen J; Chen L; Jiang H; Shen X
    Protein Sci; 2011 Aug; 20(8):1398-410. PubMed ID: 21633987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dCMP methylase by engineering thymidylate synthase.
    Agarwalla S; LaPorte S; Liu L; Finer-Moore J; Stroud RM; Santi DV
    Biochemistry; 1997 Dec; 36(50):15909-17. PubMed ID: 9398324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of Escherichia coli thymidylate synthase at tyrosine-94 by 5-imidazolylpropynyl-2'-deoxyuridine 5'-monophosphate.
    Saxl RL; Reston J; Nie Z; Kalman TI; Maley F
    Biochemistry; 2003 Apr; 42(15):4544-51. PubMed ID: 12693951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of halogen substitutions on dUMP to stability of thymidylate synthase/dUMP/mTHF ternary complex using molecular dynamics simulation.
    Kaiyawet N; Rungrotmongkol T; Hannongbua S
    J Chem Inf Model; 2013 Jun; 53(6):1315-23. PubMed ID: 23705822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint.
    Dellinger RW; Karjian PL; Neuteboom ST
    Anticancer Drugs; 2003 Jul; 14(6):449-55. PubMed ID: 12853888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of orientation and hydrogen bonding to catalysis in Asn229 mutants of thymidylate synthase.
    Finer-Moore JS; Liu L; Birdsall DL; Brem R; Apfeld J; Santi DV; Stroud RM
    J Mol Biol; 1998 Feb; 276(1):113-29. PubMed ID: 9514716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.